This study contributes to recent literature supporting the notion that epigenetic modifications driven by IL-6 are of relevance to determine the gene expression profile of cancer cells [42,43], and we can conclude that IL-6 blockage holds promises as a potential therapeutic strategy to combat breast cancer. Here, IL6 is linked to breast cancer.